Abstract-Sleep apnea is a condition commonly characterized by frequent breaks in breathing during sleep, resulting degradation in sleep quality. This paper presents results of clinical trials aimed at evaluating the use of a wearable sensor garment for in-home screening of obstructive sleep apnea and hypopnea (OSAS). The garment used in this study included ECG, position and respiration sensors. Data from the garment sensors were compared to the signal collected during an overnight routine polysomnograph (PSG) in a sleep clinic. The obtained results showed that there is a comparable performance of the garment measurements and PSG measurements. Therefore, it was concluded that it is possible to use the wearable sensor garment in an in-home screening system to observe and monitor sleep apnea events.
I. INTRODUCTION
Good mental and physical health have always been associated with a healthy sleep cycle [1] . Sleep apnea is recognized as condition that extremely worsens sleep quality. It is characterized by apnea, which is the frequent breaks in breathing, and hypopnoea, which is patterns of abnormally low breathing, resulting in sleep fragmentation and limiting the durations of deeper sleep stages. Apnea has two types, obstructive sleep apnea (OSA) and central sleep apnea (CSA). OSA is associated with intermittent blockage or reduction of the upper airway during sleep [2] while CSA is caused by the absence of neural input to the airway system from the central nervous system [3] . By definition, these breathing restrictions must be more than 10 seconds to qualify as an apneic event. Sleep apnea is a common respiratory disease, generally underdiagnosed and associated with significant morbidity and mortality [2] . Most common signs are snoring, agitated sleep, daytime fatigue, and morning headaches [4] . Researches in the field, reported that patients diagnosed with sleep apnea suffer from high potentials of accidents either at home or at work [5, 6] . Previous studies have shown that, on top of causing daytime somnolence, sleep apnea is also linked to risks of higher death rates due to cardiovascular and metabolic conditions, such as hypertension, stroke, congestive heart failure, and sudden death [4, 7, 8] . Mathias et al. estimated that sleep apnea affects 2-4% of middle-aged adults [9] . As high as 80% of apnea cases remain undiagnosed and untreated by the healthcare system [10, 27] . Sleep apnea also poses a significant economic load on healthcare systems. In 1994, the U.S. National Commission on Sleep Disorders Research found that sleep apnea's related disorders cost more than $42 million to the American taxpayer annually [8] . A more recent study in the U.S estimated that untreated sleep apnea may result in additional $3.4 billion as medical cost [11] .
These figures show the need for low cost systems that can screen efficiently for sleep apnea. While several systems were developed for diagnosis of sleep apnea [12, 13] , the commonly accepted diagnosis technique is known as a polysomnograph (PSG). The PSG approach requires an overnight stay for the patient in a specialized sleep clinic during which they are physically connected to a multi-sensor system that records data such as measurement of the heart (electrocardiogram (ECG)), respiratory airflow, respiratory effort and pulse oximetry [13] . Patient's bed position and the snoring levels are also frequently recorded and may be used to aid in differential diagnosis.
In addition to the discomfort of wearing multiple sensors and devices, which tend to fail unpredictably, patients can experience an abnormal sleep due to the change of the surrounding and restricted movement which creates a highly artificial environment, with unknown impact on appearance of symptoms. Thus, results of such studies can be inconclusive and require additional overnight evaluations. The cost of one overnight PSG is estimated at around $1000 [14] , accompanied with the need for a trained technician to process the large quantity of data, accumulated during the procedure. Waiting lists for admission to sleep clinics are currently 6 months long in USA [14] , which can be added as additional factor that delays diagnosis and treatment. With demographic changes and increasing average population age and weight, the diagnostic pressure to health systems is constantly increasing and the waiting list situation is certain to become worse.
In order to overcome these issues with the PSG diagnostic methods, researchers have looked at other approaches that can substitute or reduce the complexity of the PSG system. Some researchers used ECG signals to extract respiration rates [15] and differentiate between obstructive and central apnea events [16, 17] . Other work has focused on developing algorithms to extract sleep apnea events from data collected from ECG, respiration and accelerometer signals [18, 19] . Another obvious solution would be to detect OSA and CSA within the home environment. Existing commercial equipment for home diagnosis of OSA, such as the Edentec Monitoring System, Embletta, Sibel Home, Bedbugg, NovaSom, WatchPAt, ApneaLink, SOMNOcheck, Stardust II, Apnomonitor, and Apnea Risk Evaluation System (ARES) [20] are considered expensive, ranging between €300 and €3000 per item, and still need physical connection to the patient with cables and connections that can be easily dislodged during sleep [2, 28] similar to the PSG. As a result, it is obvious that there is a need for a solution that simplifies methods for screening sleep apnea events, while also providing a platform for rapid preclinical screening at home. Such an approach should improve efficiency of clinical PSG facilities in order to counteract the increasing backlog in diagnostics.
This paper presents the results of clinical trials into monitoring and recording ECG, thoracic movements and position signal of a patient during sleep with a commercial sports sensor garment, in order to assess its potential to 1. Assist the established PSG system in diagnostic decision making; 2. Provide the basis of a home-based diagnostic platform.
II. MATERIALS AND METHODS
Data from a standard PSG system and the wearable garment were recorded simultaneously in a specialized sleep clinic. All analyzed data was recorded during a previously scheduled appointment for a routine overnight diagnostic stay for sleep apnea assessment at St. Joseph's Clinic (affiliated to Beaumont Hospital), Raheny, Dublin, Ireland.
This section describes the clinical test conditions and methodology for in-vivo recording, followed by a comparison of the results generated by the standard PSG and the wearable garment.
A. Clinical Trials
Using the wearable garment, data was recorded from 32 patients during a routine PSG overnight recording in the sleep clinic. Ethical consent was granted by the Beaumount Research Ethics Committee (Study 13/80, "Use of a wearable sensor system and acoustic recording to monitor sleep apnoea", Shirley Coyle (DCU), Dermot Diamond (DCU), Richard Costello (RCSI)). Information about names, ages and sex of the patients has been removed from data before processing.
An overnight record of patients bio-signals was performed in St. Joseph's Clinic, Raheny, Dublin, Ireland. Typically, patients arrive in the evening to the clinic where they are placed in an isolated room. The recordings start at the beginning of the night and continue through the night while the patient is asleep. During recording with the standard PSG, parallel recordings were performed with the wearable garment. The data obtained from the standard PSG are considered precise in terms of providing all detected events time and duration during the overnight trial. The purpose of this study is to show that signals obtained with the wearable garment are equivalent to the signals recorded with the standard PSG and therefore may be used in the same way to identify apnea events.
B. Polysomnograph (PSG)
PSG is regarded as the standard method of diagnosis of sleep apnea events. During PSG recording, several physiological signals are monitored, which includes, respiration flow, thorax effort, oxygen saturation, heart rate and respiration rate. The patient's position and snoring output are also recorded. At the end of the recording, a trained clinician retrieves the recorded data and analyses the signals, e.g. by semi-automatically tagging the epochs relating to apneic events. The epochs are marked as either obstructive apnea, central apnea, hypoapnoea or mixed apnea depending on their nature. An overnight test typically provides 6-9 hours of data.
C. Equivital Wearable Garment
The wearable garment used in this study is the Equivital™ EQ02 LifeMonitor from Hidalgo Limited [21] . Using the Equivital garment, three outputs measurements are recorded: electrocardiography (ECG), respiration and the body position, see Fig. 1 . The Equivital system is a wearable garment mainly made of textile knitted sensors [15] . The ECG was measured with three fabric electrodes placed along the width of the ribcage. Such sensors eliminate the need for adhesive electrodes, thereby, reducing occasional skin irritation [10] . A piezo-resistive knitted textile stretch sensor is used to record the respiration signal. This sensor is located at the front of the chest strap as shown in Fig. 1 . Upon inhalation and exhalation, forces applied on the stretch sensor vary resulting in a change of the resistance measured at the extremities of the piezo- resistive knitted textile. This resistance change is subsequently associated with a variation in lung volume.
The sampling rate of the respiration sensor is 25.6 Hz. Body position is calculated using an orthogonal tri-axial accelerometer located in the recording module shown in Fig. 1 . The accelerometer has a sampling rate of 25.6 Hz.
The Equivital system also incorporates a thermometer to monitor skin temperature. The temperature data was not used in this study except to confirm that the wearable garment was continuously attached to the patient. The Equivital garment itself can be firmly attached to the patient using the shoulder strap and secured around the thorax with fasteners. The wearable garment comes in various sizes. The recording module, the Sensor Electronics Module (SEM). The SEM module integrates the accelerometer and the data storage SD card, and is securely located in a pouch at the front of the garment. Wetting of the ECG electrodes was only done only during pre-tests. This was performed to allow for quicker and easier application of the sensors. At the end of the trial, the data can be retrieved from the recording module using the Equivital™ Manager software and exported into Excel for further processing and analysis.
D. Data processing
Once the data was retrieved from the SEM and exported into a spreadsheet, signals from both the SEM and PSG files were pre-processed prior to comparison. Using MATLAB ®, several processing steps were applied to the signals. Initially, the relevant signals from PSG were extracted and normalised. The data was also re-sampled to match the sampling rates of the SEM. Concerning the respiration signal, it was band-pass filtered between 0.05 Hz and 0.8 Hz as 0.8 Hz is considered the maximum frequency of human breathing [22] . As to the position signal, both PSG and SEM data was extracted and resampled at 1 sample per second and intensity-normalised. The PSG data distinguished between right and left (lying) positions, while the preliminary processing of SEM data showed some difficulties in identifying the right position, thus it was nominated as Right/Side. The other possible outputs were, prone, supine and up. Another output is defined as "unknown" for SEM data. This output is likely representing in most cases a non-supine position (Up or seated). For PSG, the technician may manually identified the Up position. Afterwards, and for the purpose of comparison, the time scale for respective signals from PSG and SEM were aligned and graphs showing the two signals for each patient were generated and observed.
III. RESULTS AND DISCUSSION

A. ECG Signal
The reliability of ECG signal collected by Equivital LifeMonitor systems was previously confirmed by several researchers [23] [24] [25] [26] and from this work, it can be concluded that the ECG data collected from both PSG and SEM can be used interchangeably to monitor the heart activity of patients as part of a sleep apnea screening system. Fig. 2 shows the respiration signals for patient number 2 obtained from PSG (top) and SEM (bottom), respectively. It can be observed that there is a correlation between the two signals. The PSG signal presented a saturation effect-i.e. between 20000s and 25000s. In addition, the sampling rate of the PSG respiration signal, 32 samples per second, was higher than for SEM, which might explain the difference between the two signals. Nonetheless, it can be clearly observed that the two signals are following the same trend and display multiple synchronous events. Similar correlation in respiration signal between the two sensors was observed with all 32 patients. This observation reinforces the suitability of using the Equivital system to detect thoracic movement during sleep and from this, evaluate respiration changes for the purpose of screening sleep apnea events. Fig. 3 and Fig. 4 shows the signals from PSG and SEM for patients 1 and 27. Although the processing of SEM data had difficulties in differentiating between Right and Left positions, it seems overall to be more sensitive than PSG position sensor. However, this will have to be confirmed through further studies incorporating video recording during clinical trials. While there are some small differences, it can still be observed that the PSG and SEM signals are strongly correlated and can be interchangeably used to determine the position of the patient while asleep. This position data could be an important element of a new screening system based on audio signal processing. While audio signals recorded during sleeping may be used to identify sleep apnea events, information about the position of the patient is also required for correct diagnosis and detection of artefacts. This will be the subject of the next phase of this study.
B. Respiration Signal
C. Position Signal
IV. CONCLUSION
In this paper, a commercially available and affordable wearable sensor garment, Equivital™ EQ02 LifeMonitor, was evaluated as a platform for potential home-based screening of sleep apnea events.
Although the evaluated system is able to partially substitute some of the signals recorded by PSG system for sleep apnea diagnostic, the assessment of further signals and processing is required [29] before larger scale of at-home screening can be performed.
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